Cargando…

A Rare Case of Invasive Cribriform Carcinoma in Male Breast

Patient: Male, 58-year-old Final Diagnosis: Invasive cribriform carcinoma Symptoms: A painful and palpable enlarging breast mass Clinical Procedure: Adjuvant chemotherapy • surgery Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Male breast cancer is a very rare disease that represents 0.6%...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Hong, Um, Eunhae, Kim, Jae Il, Park, Ji Yeon, Lee, Ji Young, Kim, Ji-Ye, Chang, Sunhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909612/
https://www.ncbi.nlm.nih.gov/pubmed/36739475
http://dx.doi.org/10.12659/AJCR.938939
_version_ 1784884610595815424
author Ju, Hong
Um, Eunhae
Kim, Jae Il
Park, Ji Yeon
Lee, Ji Young
Kim, Ji-Ye
Chang, Sunhee
author_facet Ju, Hong
Um, Eunhae
Kim, Jae Il
Park, Ji Yeon
Lee, Ji Young
Kim, Ji-Ye
Chang, Sunhee
author_sort Ju, Hong
collection PubMed
description Patient: Male, 58-year-old Final Diagnosis: Invasive cribriform carcinoma Symptoms: A painful and palpable enlarging breast mass Clinical Procedure: Adjuvant chemotherapy • surgery Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Male breast cancer is a very rare disease that represents 0.6% of all breast carcinomas. Among breast carcinomas, invasive cribriform carcinoma (ICC) is a rare type of breast carcinoma and is more common in older women, with only a few cases in men reported. We present a case of male breast cancer with ICC. CASE REPORT: A 58-year-old man presented with a painful and palpable mass in the left breast, which was diagnosed as breast cancer of the ICC type. The patient underwent total mastectomy plus sentinel lymph node biopsy. On the microscope, the tumor was composed of more than 90% cribriform glands with comedo necrosis and dystrophic calcification. On immunohistochemical (IHC) staining, it appeared to be a luminal breast cancer. The IHC staining for c-erb B2 was equivocal (2 positive); hence fluorescence in situ hybridization was performed, and showed no amplification of the HER2/neu oncogene. The Ki-67 labeling index was 30%. The patient received radiotherapy and adjuvant systemic chemotherapy (4 cycles of docetaxel and cyclophosphamide), and has been on antiestrogen therapy (daily tamoxifen, 20 mg) for 30 months with no evidence of disease. CONCLUSIONS: ICC is a rare type of invasive carcinoma of the breast, and ICC from the male breast is extremely rare. We report, in this case, the final pathologic results of a male patient diagnosed with ICC breast cancer and treated with surgery, chemotherapy, and radiotherapy.
format Online
Article
Text
id pubmed-9909612
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-99096122023-02-10 A Rare Case of Invasive Cribriform Carcinoma in Male Breast Ju, Hong Um, Eunhae Kim, Jae Il Park, Ji Yeon Lee, Ji Young Kim, Ji-Ye Chang, Sunhee Am J Case Rep Articles Patient: Male, 58-year-old Final Diagnosis: Invasive cribriform carcinoma Symptoms: A painful and palpable enlarging breast mass Clinical Procedure: Adjuvant chemotherapy • surgery Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Male breast cancer is a very rare disease that represents 0.6% of all breast carcinomas. Among breast carcinomas, invasive cribriform carcinoma (ICC) is a rare type of breast carcinoma and is more common in older women, with only a few cases in men reported. We present a case of male breast cancer with ICC. CASE REPORT: A 58-year-old man presented with a painful and palpable mass in the left breast, which was diagnosed as breast cancer of the ICC type. The patient underwent total mastectomy plus sentinel lymph node biopsy. On the microscope, the tumor was composed of more than 90% cribriform glands with comedo necrosis and dystrophic calcification. On immunohistochemical (IHC) staining, it appeared to be a luminal breast cancer. The IHC staining for c-erb B2 was equivocal (2 positive); hence fluorescence in situ hybridization was performed, and showed no amplification of the HER2/neu oncogene. The Ki-67 labeling index was 30%. The patient received radiotherapy and adjuvant systemic chemotherapy (4 cycles of docetaxel and cyclophosphamide), and has been on antiestrogen therapy (daily tamoxifen, 20 mg) for 30 months with no evidence of disease. CONCLUSIONS: ICC is a rare type of invasive carcinoma of the breast, and ICC from the male breast is extremely rare. We report, in this case, the final pathologic results of a male patient diagnosed with ICC breast cancer and treated with surgery, chemotherapy, and radiotherapy. International Scientific Literature, Inc. 2023-02-05 /pmc/articles/PMC9909612/ /pubmed/36739475 http://dx.doi.org/10.12659/AJCR.938939 Text en © Am J Case Rep, 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Ju, Hong
Um, Eunhae
Kim, Jae Il
Park, Ji Yeon
Lee, Ji Young
Kim, Ji-Ye
Chang, Sunhee
A Rare Case of Invasive Cribriform Carcinoma in Male Breast
title A Rare Case of Invasive Cribriform Carcinoma in Male Breast
title_full A Rare Case of Invasive Cribriform Carcinoma in Male Breast
title_fullStr A Rare Case of Invasive Cribriform Carcinoma in Male Breast
title_full_unstemmed A Rare Case of Invasive Cribriform Carcinoma in Male Breast
title_short A Rare Case of Invasive Cribriform Carcinoma in Male Breast
title_sort rare case of invasive cribriform carcinoma in male breast
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909612/
https://www.ncbi.nlm.nih.gov/pubmed/36739475
http://dx.doi.org/10.12659/AJCR.938939
work_keys_str_mv AT juhong ararecaseofinvasivecribriformcarcinomainmalebreast
AT umeunhae ararecaseofinvasivecribriformcarcinomainmalebreast
AT kimjaeil ararecaseofinvasivecribriformcarcinomainmalebreast
AT parkjiyeon ararecaseofinvasivecribriformcarcinomainmalebreast
AT leejiyoung ararecaseofinvasivecribriformcarcinomainmalebreast
AT kimjiye ararecaseofinvasivecribriformcarcinomainmalebreast
AT changsunhee ararecaseofinvasivecribriformcarcinomainmalebreast
AT juhong rarecaseofinvasivecribriformcarcinomainmalebreast
AT umeunhae rarecaseofinvasivecribriformcarcinomainmalebreast
AT kimjaeil rarecaseofinvasivecribriformcarcinomainmalebreast
AT parkjiyeon rarecaseofinvasivecribriformcarcinomainmalebreast
AT leejiyoung rarecaseofinvasivecribriformcarcinomainmalebreast
AT kimjiye rarecaseofinvasivecribriformcarcinomainmalebreast
AT changsunhee rarecaseofinvasivecribriformcarcinomainmalebreast